• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在美沙酮项目中,异烟肼治疗对感染人类免疫缺陷病毒(HIV)和未感染HIV的注射吸毒者潜伏性结核感染的有效性。

Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs.

作者信息

Scholten Jerod N, Driver Cynthia R, Munsiff Sonal S, Kaye Katherine, Rubino Mary Ann, Gourevitch Marc N, Trim Caroline, Amofa James, Seewald Randy, Highley Esther, Fujiwara Paula I

机构信息

New York City Department of Health and Mental Hygiene, New York, USA.

出版信息

Clin Infect Dis. 2003 Dec 15;37(12):1686-92. doi: 10.1086/379513. Epub 2003 Nov 17.

DOI:10.1086/379513
PMID:14689352
Abstract

Injection drug users (IDUs) were heavily affected by the tuberculosis (TB) resurgence in New York City in the 1990s. We assessed the effectiveness of screening for latent TB infection in methadone users and of selective treatment with isoniazid. Risk for future TB was classified as low or high on the basis of tuberculin, anergy, and HIV test results. The cohort of 2212 IDUs was followed up for a median of 4.2 years; 25 IDUs, of whom 20 (80%) were infected with human immunodeficiency virus (HIV), developed TB. In an adjusted Cox proportional hazards model of high-risk IDUs, the risk of TB was associated with HIV infection (HR 10.3; 95% CI, 3.4-31.3); receipt of <6 months of isoniazid therapy (HR 7.6; 95% CI, 1.02-57.1); a CD4+ T lymphocyte count of <200 cells/mm3 (HR 6.6; 95% CI, 1.7-25.9); and tuberculin positivity (HR 4.0; 95% CI, 1.6-10.2). Treatment with isoniazid was beneficial in HIV-infected, tuberculin-positive IDUs.

摘要

注射吸毒者(IDUs)在20世纪90年代纽约市结核病(TB)卷土重来时受到了严重影响。我们评估了对美沙酮使用者进行潜伏性结核感染筛查以及使用异烟肼进行选择性治疗的有效性。根据结核菌素、无反应性和HIV检测结果,将未来患结核病的风险分为低风险或高风险。对2212名注射吸毒者队列进行了中位数为4.2年的随访;25名注射吸毒者患了结核病,其中20名(80%)感染了人类免疫缺陷病毒(HIV)。在对高风险注射吸毒者进行校正的Cox比例风险模型中,结核病风险与HIV感染相关(风险比[HR]10.3;95%置信区间[CI],3.4 - 31.3);接受异烟肼治疗<6个月(HR 7.6;95% CI,1.02 - 57.1);CD4 + T淋巴细胞计数<200个细胞/mm3(HR 6.6;95% CI,1.7 - 25.9);以及结核菌素阳性(HR 4.0;95% CI,1.6 - 10.2)。对感染HIV且结核菌素阳性的注射吸毒者使用异烟肼治疗有益。

相似文献

1
Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs.在美沙酮项目中,异烟肼治疗对感染人类免疫缺陷病毒(HIV)和未感染HIV的注射吸毒者潜伏性结核感染的有效性。
Clin Infect Dis. 2003 Dec 15;37(12):1686-92. doi: 10.1086/379513. Epub 2003 Nov 17.
2
Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.异烟肼化学预防对HIV相关分枝杆菌病的影响。
Arch Intern Med. 1996 Apr 22;156(8):889-94.
3
[HIV infection, tuberculosis and tuberculin test in Switzerland. The Swiss HIV Cohort Study].[瑞士的艾滋病毒感染、结核病与结核菌素试验。瑞士艾滋病毒队列研究]
Schweiz Med Wochenschr. 1996 Nov 23;126(47):2007-12.
4
Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis.人类免疫缺陷病毒对一组静脉吸毒者结核病发病率的影响:抗结核化学预防的效果。
Int J Tuberc Lung Dis. 1998 Feb;2(2):140-6.
5
A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.对结核高危的无反应能力及感染人类免疫缺陷病毒者使用异烟肼的对照试验。艾滋病临床研究特里·贝恩社区项目。
N Engl J Med. 1997 Jul 31;337(5):315-20. doi: 10.1056/NEJM199707313370505.
6
Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005.2002年至2005年印度浦那地区感染艾滋病毒的妇女及其婴儿的产后结核病发病率和死亡率
Clin Infect Dis. 2007 Jul 15;45(2):241-9. doi: 10.1086/518974. Epub 2007 Jun 4.
7
Risk factors for development of tuberculosis after isoniazid chemoprophylaxis in human immunodeficiency virus-infected patients.人类免疫缺陷病毒感染患者接受异烟肼化学预防后发生结核病的危险因素。
Clin Infect Dis. 2002 Feb 1;34(3):386-9. doi: 10.1086/324746. Epub 2001 Dec 19.
8
Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania.坦桑尼亚 HIV 感染、TST 阳性成人中异烟肼预防治疗的完成情况与生存。
Int J Tuberc Lung Dis. 2011 Nov;15(11):1515-21, i. doi: 10.5588/ijtld.10.0788.
9
Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival.人类免疫缺陷病毒感染者的异烟肼预防性治疗。对结核病发生和生存的长期影响。
Arch Intern Med. 1997;157(15):1729-34.
10
Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.1997年至2000年在纽约市接受基于利福平或利福布汀治疗方案的HIV感染结核病患者的复发及获得性利福平耐药情况。
Clin Infect Dis. 2005 Jul 1;41(1):83-91. doi: 10.1086/430377. Epub 2005 May 26.

引用本文的文献

1
Willingness of receiving preventive treatment and its determinants among individuals with latent tuberculosis infection in Shenzhen, China.中国深圳潜伏性结核感染个体接受预防性治疗的意愿及其决定因素
BMC Infect Dis. 2025 May 4;25(1):651. doi: 10.1186/s12879-025-11026-x.
2
Isoniazid use, effectiveness, and safety for treatment of latent tuberculosis infection: a systematic review.异烟肼用于治疗潜伏性结核感染的使用、疗效和安全性:系统评价。
Rev Soc Bras Med Trop. 2024 Mar 25;57:e004022024. doi: 10.1590/0037-8682-0504-2023. eCollection 2024.
3
Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review.
3 个月异烟肼和利福喷汀与 9 个月异烟肼治疗潜伏性结核感染的成本效益比较:系统评价。
BMC Public Health. 2022 Dec 7;22(1):2292. doi: 10.1186/s12889-022-14766-6.
4
Initiation and completion rates for latent tuberculosis infection treatment: a systematic review.潜伏性结核感染治疗的起始率和完成率:一项系统评价
BMC Infect Dis. 2016 May 17;16:204. doi: 10.1186/s12879-016-1550-y.
5
Tuberculosis screening in a novel substance abuse treatment center in Malaysia: implications for a comprehensive approach for integrated care.马来西亚新型药物滥用治疗中心的结核病筛查:综合关怀一体化方法的启示。
J Subst Abuse Treat. 2014 Feb;46(2):144-9. doi: 10.1016/j.jsat.2013.08.023. Epub 2013 Sep 24.
6
Tuberculosis and illicit drug use: review and update.结核病与非法药物使用:综述与更新
Clin Infect Dis. 2009 Jan 1;48(1):72-82. doi: 10.1086/594126.
7
Trends in tuberculosis/human immunodeficiency virus comorbidity, United States, 1993-2004.1993 - 2004年美国结核病/人类免疫缺陷病毒合并感染趋势
Arch Intern Med. 2007 Dec 10;167(22):2443-52. doi: 10.1001/archinte.167.22.2443.